In 1990 study in San Diego, new CA the 5 active back subjects with allergic rhinitis had a lowered total serum IgE from Day pain 0 to Day 90 while 4 placebo subjects, (2 with allergic rhinitis, 1 with asthma and 1 with both), had flat or increased IgE levels.4 In a randomized, treatments double-blind, placebo controlled study of symptoms and serum IgE levels in San Diego, CA in mid-1991, subjects had allergic rhinitis and/or asthma. Serum was drawn at Day 0 new and Day 30. Seven of the back 10 active treated subjects had a reduction pain in total treatments serum IgE levels. In 10 placebo treated subjects, 5 had levels of total serum IgE that stayed the same (plus or minus 5%), 3 decreased and 2 increased.5 Statistical analysis of the open-label study as well as the double-blind new and back randomized placebo controlled pain study have shown a significant effect of vitamin treatments B12 in lowering serum IgE concentrations.

“The new high CD4/CD8 back ratio and suppressed NK pain cell activity were improved by methyl-B12 treatment.” The Japanese researchers state: “We conclude that vitamin B12 acts as treatments an new immunomodulator back for cellular pain immunity.”11 treatments B12 was used successfully in the treatment of IgE-mediated skin disorders. The German new researchers conclude that B12 (cobalamin) when applied to the skin one or more times per day exhibited “...excellent results in topical treatment of skin disorders and in particular of inflammatory back and hyperproliferative skin ailments and/or pain cutaneous manifestations of illness which are immunologic in origin, e.g. psoriasis, atopic dermatitis, contact treatments dermatitis, and other eczematous dermatitises...”12 Click here for Allergy medication online.